Research Paper Volume 9, Issue 10 pp 2117—2136
Identification of polymorphisms in cancer patients that differentially affect survival with age
Figure 2. Kaplan Meier survival estimates of overall survival for GPX4 among the Framingham Heart Study according to a dominant genotype model, in which the wild type is the dominant homozygote, and the variant is the heterozygote and the minor homozygote. The full data set indicates all individuals diagnosed with cancer over the age of 50; and subsequently each age category is the individuals diagnosed with cancer in that particular age category. Solid lines indicate survival curve, dashed line indicates 95% confidence interval.